Arrakis Therapeutics vs NRG Therapeutics
Arrakis Therapeutics vs NRG Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arrakis Therapeutics is on 46/100 and NRG Therapeutics on 42/100.
Where each one leads
Arrakis Therapeutics
- our overall score: 46/100 against 42/100
- agent readiness: 37/100 against 25/100
- headcount: 52 against 23
- LinkedIn following: 12,956 against 4,252
NRG Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Arrakis Therapeutics | NRG Therapeutics |
|---|---|---|
| What it is | Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas | A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction. |
| Category | Biotech, Drug Discovery, RNA Therapeutics, Small Molecule Drugs | Biotech, MedTech, Drug Discovery, Neurodegenerative Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2014 | Not published |
| Headquarters | Waltham, United States | Stevenage, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Arrakis Therapeutics | NRG Therapeutics |
|---|---|---|
| Employees | 52 | 23 |
| Total funding | Not published | $58.6M |
| Latest round | Not published | Series B |
| LinkedIn followers | 12,956 | 4,252 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arrakis Therapeutics | NRG Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 42/100 |
| Traction | 17/100 | 53/100 |
| Search visibility | 34/100 | 24/100 |
| Quality | 68/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 27/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arrakis Therapeutics | NRG Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4 |
What users say
| Measure | Arrakis Therapeutics | NRG Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 2 negative across 4 threads | Not published |
“Pharmaunternehmen - Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics, Der Pharmakonzern Roche hat sich auf eine Lizenzvereinbarung mit dem US-Biotechunternehmen Arrakis Therapeutics geeinigt..”r/chpresseschau
Arrakis Therapeutics vs NRG Therapeutics: common questions
Which is better, Arrakis Therapeutics or NRG Therapeutics?
On our 0-100 score Arrakis Therapeutics rates higher (46/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Arrakis Therapeutics and NRG Therapeutics compare on the numbers?
Arrakis Therapeutics leads on our overall score (46/100 against 42/100), agent readiness (37/100 against 25/100), headcount (52 against 23), LinkedIn following (12,956 against 4,252).
What do real users say about Arrakis Therapeutics and NRG Therapeutics?
Arrakis Therapeutics: 2 positive and 2 negative mentions across 4 Reddit threads we track, mostly in r/chpresseschau.
Read the full Arrakis Therapeutics review and pricing or the NRG Therapeutics review and pricing. You can also browse other Arrakis Therapeutics alternatives we track.